Description
SPEVIGO (spesolimab-sbzo) injection
US Food and Drug Administration (FDA) has approved SPEVIGO® (spesolimab-sbzo) injection for the treatment of generalized pustular psoriasis (GPP) in adults and pediatric patients aged 12 and above weighing ≥40 kg.
Generalized pustular psoriasis (GPP) is a rare and potentially-life threatening disease characterized by extensive eruption of pustules on the skin, with or without systemic inflammation and with or without plaque psoriasis.
Spesolimab (SPEVIGO) is an IL-36 receptor antagonist being developed by Boehringer Ingelheim for the treatment of various immune-mediated disorders. Spesolimab was given orphan drug designation by the US FDA in October 2018 for the treatment of GPP flares in adults. In December 2021, the US FDA accepted a biologics license application and granted priority review for spesolimab for the treatment of GPP flares; prior to this, spesolimab had been granted breakthrough therapy designation . On 1 September 2022, spesolimab received its first approval in the USA for the treatment of GPP flares in adults.
Get Access to SPEVIGO (spesolimab-sbzo) injection In India
On request it available to patient and doctors. Medvitaz Pharma is equipped to facilitate the distribution of SPEVIGO (spesolimab-sbzo) injection (prescription medications) worldwide and throughout India upon completion of necessary legal procedures, if applicable.
To inquire about the price of either the branded medication “SPEVIGO (spesolimab-sbzo) injection” or the generic version “spesolimab-sbzo injection” for personal use under patient-specific treatment in various cities including Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura, Sikkim, and others in India, please fill out the request form. Upon receiving your request and assessing the delivery process, we will provide you with an estimated price for the medication within 24 hours.
For any inquiries or assistance, please reach out to our Patient Support Team. We are available to assist you from Monday to Friday, between 9:00 and 19:00 IST. You can contact us via email at [email protected], toll-free at +91 8750295029, or through WhatsApp at +91-8750295029.